Cargando…

Ebselen: A promising therapy protecting cardiomyocytes from excess iron in iron-overloaded thalassemia patients

Iron-overload-associated cardiomyopathy has been one of the primary causes of mortality in thalassemia patients with iron burden. There is growing evidence citing the beneficial effects of ebselen as an antioxidant selectively blocking the divalent metal transporter 1 (DMT-1) to deter iron ingress i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghazaiean, Mobin, Aliasgharian, Aily, Karami, Hossein, Darvishi-Khezri, Hadi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350894/ https://www.ncbi.nlm.nih.gov/pubmed/37465348 http://dx.doi.org/10.1515/med-2023-0733

Ejemplares similares

Ferritin thresholds for cardiac and liver hemosiderosis in β-thalassemia patients: a diagnostic accuracy study
por: Darvishi-Khezri, Hadi, et al.
Publicado: (2022)

Treatment Status of Patients with B-Thalassemia Major in Northern Iran: Thalassemia Registry System
por: KOSARYAN, Mehrnoush, et al.
Publicado: (2019)

Combination Iron Chelation Therapy with Deferiprone and Deferasirox in Iron-Overloaded Patients with Transfusion-Dependent β-Thalassemia Major
por: Karami, Hossein, et al.
Publicado: (2017)

Moderate to severe liver siderosis and raised AST are independent risk factors for vitamin D insufficiency in β-thalassemia patients
por: Darvishi-Khezri, Hadi, et al.
Publicado: (2020)

Potential Effects of Silymarin and Its Flavonolignan Components in Patients with β-Thalassemia Major: A Comprehensive Review in 2015
por: Darvishi Khezri, Hadi, et al.
Publicado: (2016)

Administration of Intravenous Zoledronic Acid Every 3 Months vs. Annually in β-thalassemia Patients with Low Bone Mineral Density: a Retrospective Comparison of Efficacy
por: Darvishi-Khezri, Hadi, et al.
Publicado: (2018)

Amlodipine: Can act as an antioxidant in patients with transfusion‐dependent β‐thalassemia? A double‐blind, controlled, crossover trial
por: Darvishi‐Khezri, Hadi, et al.
Publicado: (2022)

Relationship between medical history and multiple sclerosis: A-case-control study
por: esfandiari, Fatemeh, et al.
Publicado: (2023)

Zinc Supplementation in Adult Mechanically Ventilated Trauma Patients is Associated with Decreased Occurrence of Ventilator-associated Pneumonia: A Secondary Analysis of a Prospective, Observational Study
por: Hasanzadeh Kiabi, Farshad, et al.
Publicado: (2017)

Cellular Electrophysiology of Iron-Overloaded Cardiomyocytes
por: Siri-Angkul, Natthaphat, et al.
Publicado: (2018)

The improvement of pulmonary artery pressure after bosentan therapy in patients with β-thalassemia and Doppler-defined pulmonary arterial hypertension
por: Karami, Hossein, et al.
Publicado: (2018)

β-Thalassemia: HiJAKing Ineffective Erythropoiesis and Iron Overload
por: Melchiori, Luca, et al.
Publicado: (2010)

Myocardial iron overload in sickle/thalassemia patients of Italian origin
por: Meloni, Antonella, et al.
Publicado: (2013)

Myocardial iron overload in thalassemia major. How early to check?
por: Meloni, Antonella, et al.
Publicado: (2014)

Treating iron overload in patients with non-transfusion-dependent thalassemia
por: Taher, Ali T, et al.
Publicado: (2013)

Treating thalassemia major-related iron overload: the role of deferiprone
por: Berdoukas, Vasilios, et al.
Publicado: (2012)

Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia
por: Bou-Fakhredin, Rayan, et al.
Publicado: (2017)

Green synthesis of safe zero valent iron nanoparticles by Myrtus communis leaf extract as an effective agent for reducing excessive iron in iron-overloaded mice, a thalassemia model
por: Eslami, Shahram, et al.
Publicado: (2018)

Brain iron content in systemic iron overload: A beta-thalassemia quantitative MRI study
por: Manara, Renzo, et al.
Publicado: (2019)

Global longitudinal strain as an Indicator of cardiac Iron overload in thalassemia patients
por: Abtahi, Firoozeh, et al.
Publicado: (2019)

Iron overload status in patients with non-transfusion-dependent thalassemia in China
por: Huang, Yumei, et al.
Publicado: (2022)

Hepcidin gene polymorphisms and iron overload in β-thalassemia major patients refractory to iron chelating therapy
por: Zarghamian, Parinaz, et al.
Publicado: (2020)

Prevalence of iron overload complications among patients with β-thalassemia major treated at Dubai Thalassemia Centre
por: Belhoul, Khawla Mohammed, et al.
Publicado: (2013)

Silymarin therapy and improvement of cardiac outcome in patients with β-thalassemia major
por: Khezri, Hadi Darvishi, et al.
Publicado: (2016)

Study of the effect of iron overload on the function of endocrine glands in male thalassemia patients
por: Abdulzahra, Mohammed Saied, et al.
Publicado: (2011)

How Early Can Myocardial Iron Overload Occur in Beta Thalassemia Major?
por: Yang, Gaohui, et al.
Publicado: (2014)

Effect of iron overload on renal functions and oxidative stress in beta thalassemia patients
por: Rasool, Mahmood, et al.
Publicado: (2016)

Pulmonary function in patients with transfusion-dependent thalassemia and its associations with iron overload
por: Chan, Kate C., et al.
Publicado: (2023)

Safety and Efficacy of the New Combination Iron Chelation Regimens in Patients with Transfusion-Dependent Thalassemia and Severe Iron Overload
por: Origa, Raffaella, et al.
Publicado: (2022)

Comparison Between Hesperidin, Coumarin, and Deferoxamine Iron Chelation and Antioxidant Activity Against Excessive Iron in the Iron Overloaded Mice
por: Aalikhani, Mahdi, et al.
Publicado: (2022)

Naringin Chelates Excessive Iron and Prevents the Formation of Amyloid-Beta Plaques in the Hippocampus of Iron-Overloaded Mice
por: Jahanshahi, Mehrdad, et al.
Publicado: (2021)

Two trade names of deferasirox (Osveral® and Exjade®) in reduction of iron overload parameters in major beta-thalassemia patients: A randomized open labeled clinical trial
por: Rafati, Mohammadreza, et al.
Publicado: (2022)

Ebselen, Iron Uptake Inhibitor, Alleviates Iron Overload-Induced Senescence-Like Neuronal Cells SH-SY5Y via Suppressing the mTORC1 Signaling Pathway
por: Mukem, Sirirak, et al.
Publicado: (2023)

Right ventricular volumes and function in thalassemia major patients in the absence of myocardial iron overload
por: Carpenter, John-Paul, et al.
Publicado: (2010)

An automatic method for myocardial T2* curve fitting in thalassemia patients with severe iron overload
por: Meloni, Antonella, et al.
Publicado: (2013)

Therapeutic Value of Combined Therapy with Deferasirox and Silymarin on Iron Overload in Children with Beta Thalassemia
por: Hagag, Adel A., et al.
Publicado: (2013)

Oral exfoliative cytology as a screening tool for iron overload in β-thalassemia patients
por: Rathore, Ajit Singh, et al.
Publicado: (2016)

Estimation of iron overloads using oral exfoliative cytology in beta-thalassemia major patients
por: Leekha, Swati, et al.
Publicado: (2016)

Liver Enzymes in Children with beta-Thalassemia Major: Correlation with Iron Overload and Viral Hepatitis
por: Salama, Khaled M., et al.
Publicado: (2015)

Iron overload assessment in β Thalassemia Major – is T2* Magnetic Resonance Imaging the answer?
por: Ali, Natasha
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rulgufo45s15doikse66kp7d7d